Skip to main content

Table 2 Number of lawsuits involving the 20 most requested medicines, São Paulo, 2010–2014

From: Legal access to medications: a threat to Brazil’s public health system?

Item Number (%)
Insulin glargine - vial/cartridge/disposable pen 3539 (6.3)
Insulin aspart - vial/cartridge/disposable pen 1849 (3.3)
Methylphenidate - capsule/extended-release tablet 1773 (3.1)
Ranibizumab - ampoule 1710 (3.0)
Insulin lispro - vial/cartridge/disposable pen 1565 (2.8)
Acetylsalicylic acid (100–325 mg) - tablet/coated tablet/slow-release tablet 1309 (2.3)
Clopidogrel - tablet 1224 (2.2)
Levothyroxine (38–200 mcg) - tablet 966 (1.7)
Glucosamine + chondroitin - sachet/tablet 968 (1.7)
Cinacalcet hydrochloride - coated tablet 906 (1.6)
Boceprevir 200 mg - gelatine capsule 844 (1.5)
Simvastatin (5–80 mg) - tablet 842 (1.5)
Insulin detemir - cartridge/disposable pen 834 (1.5)
Omeprazole - tablet/capsule 799 (1.4)
Insulin glulisine - vial/cartridge/disposable pen 801 (1.4)
Sodium hyaluronate - injectable solution/vial 771 (1.4)
Pregabalin - capsule 761 (1.4)
Metformin + vildagliptin - capsule 733 (1.3)
Rosuvastatin (5–40 mg) - tablet 730 (1.3)
Zoledronic acid - injectable solution/vial 675 (1.2)
Subtotal: 23,559 (41.9)
TOTAL 56,345 (100)
  1. Source: S-Codes